A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates

Tom H. Johnston, Zak Millar, Philippe Huot, Keith Wagg, Sherri Thiele, Danielle Salomonczyk, Christopher J. Yong-Kee, Michael N. Gandy, Matthew McIldowie, Katie D. Lewis, Jordi Gomez-Ramirez, Joohyung Lee, Susan H. Fox, Mathew Martin-Iverson, Joanne E. Nash, Matthew J. Piggott*, Jonathan M. Brotchie

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    22 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates'. Together they form a unique fingerprint.

    Neuroscience

    Pharmacology, Toxicology and Pharmaceutical Science